MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET 2019-2028

Market By Drug Type, Technology, Service, End-user, And Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research, the drug discovery market in the Middle East and Africa is expected to grow exponentially at a CAGR of 5.71% for the forecasting phase of 2019-2028.


Report scope can be customized per your requirements. Request For Customization

Following are the countries that are included in the drug discovery market analysis of the Middle East and Africa region:

•           Saudi Arabia

•           Turkey

•           The United Arab Emirates

•           South Africa

•           Rest of MEA countries

The drug discovery market in the region is driven primarily by government initiatives to propel growth in scientific research. For instance, South Africa’s Biomedical Translational Research Initiative (BTRI) was initiated by the University of Cape Town (UCT) and the CSIR (Council of Scientific and Industrial Research) for biomedical research. The main goal of the initiative is to bring various institutes to join hands to develop translational research. This is expected to increase the research activities in the country, which, in turn, will further boost the drug discovery process. This will benefit the studied market in the Middle East and Africa.

The high pervasiveness of acute & chronic diseases and the rising healthcare expenses are the factors fueling the growth of Saudi Arabia’s drug discovery market. The concept of drug discovery encompasses all the costs incurred by a drug discovery company. For effectively executing the process of drug discovery, the cost of hardware and software is considerably high. Here, the overall expenditure on research and development is low. Hence, the funding available to each company in the market is far lesser than that available in the developed regions. This might negatively impact the market growth. However, the high prevalence of chronic diseases in the nation is creating the demand for novel drug development for the treatment of diseases. This is one of the driving forces of the KSA drug discovery market during the forecast period.

Becton Dickinson, and Company (BD) is a renowned med-tech company. It develops, manufactures, and sells medical devices, diagnostic products, and laboratory equipment. The company’s major products include syringes & pen needles, IV catheters, infusion pumps & disposables, respiratory ventilation & diagnostics equipment, automated medication dispensing systems, diagnostics specimens, and instruments to detect a broad range of infectious diseases, HAIs, and cancer. The company offers its products to clinical laboratories, healthcare institutions, life science researchers, the pharma industry, and the general public. BD has a notable presence in the Middle East and Africa.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER'S FIVE FORCES MODEL

2.2.1.   THREATS OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. COVID-19 AND ITS IMPACT ON DRUG DISCOVERY MARKET

2.4. PESTLE OUTLOOK

2.5. REGULATORY FRAMEWORK

2.6. VALUE CHAIN OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   GROWING AGED POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.9.3.   RISE IN HEALTHCARE EXPENDITURE

2.9.4.   SURGE IN LIFESTYLE-ORIENTED DISEASES

2.10.   MARKET RESTRAINTS

2.10.1.   DELAY IN PRODUCT LAUNCHES

2.10.2.    RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS

2.11.   MARKET OPPORTUNITIES

2.11.1.   SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES

2.11.2.   RISING DEMAND FOR SPECIALTY MEDICINES

2.12.    MARKET CHALLENGES

2.12.1.     POOR REIMBURSEMENTS POLICIES IN EMERGING NATIONS

2.12.2.   STRINGENT GOVERNMENT REGULATIONS

3.    DRUG DISCOVERY MARKET OUTLOOK - BY DRUG TYPE

3.1. SMALL MOLECULE DRUG

3.2. BIOLOGIC DRUG

4.    DRUG DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY

4.1. HIGH THROUGHPUT SCREENING

4.2. BIOCHIPS

4.3. BIOINFORMATICS

4.4. PHARMACOGENOMICS AND PHARMACOGENETICS

4.5. COMBINATORIAL CHEMISTRY

4.6. NANOTECHNOLOGY

4.7. SPECTROSCOPY

4.8. METABOLOMICS

4.9. OTHER TECHNOLOGIES

5.    DRUG DISCOVERY MARKET OUTLOOK - BY SERVICE

5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

5.2. CHEMICAL SERVICES

5.3. BIOLOGICAL SERVICES

5.4. OTHER PHARMACEUTICAL SERVICES

6.    DRUG DISCOVERY MARKET OUTLOOK - BY END-USER

6.1. RESEARCH INSTITUTES

6.2. PHARMACEUTICAL COMPANIES

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4. OTHER END-USERS

7.    DRUG DISCOVERY MARKET – MIDDLE EAST AND AFRICA

7.1. COUNTRY ANALYSIS

7.1.1.   SAUDI ARABIA

7.1.2.   TURKEY

7.1.3.   UNITED ARAB EMIRATES

7.1.4.   SOUTH AFRICA

7.1.5.   REST OF MIDDLE EAST AND AFRICA

8.    COMPANY PROFILES

8.1. 3M COMPANY

8.2. ABBOTT LABORATORIES INC

8.3. AGILENT TECHNOLOGIES INC

8.4. ANTARES PHARMA INC

8.5. ASTRAZENECA PLC

8.6. BAYER AG

8.7. BECTON DICKINSON & COMPANY (BD)

8.8. BOEHRINGER INGELHEIM

8.9. ELI LILY AND COMPANY

8.10.   F HOFFMANN-LA ROCHE LTD

8.11.   GLAXOSMITHKLINE LLC

8.12.   JOHNSON & JOHNSON

8.13.   MERCK & CO INC

8.14.     NOVARTIS

8.15.   PFIZER INC

8.16.   SANOFI

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 2        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 3        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 4        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 5        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 6        MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)

FIGURE 3      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)

FIGURE 4      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)

FIGURE 5      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 10   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2028 ($ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2028 ($ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 16   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)

FIGURE 18   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)

FIGURE 19   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2028 ($ MILLION)

FIGURE 21   SAUDI ARABIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 22   TURKEY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 23   UNITED ARAB EMIRATES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 24   SOUTH AFRICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 25   REST OF MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;